Management of low-risk prostate cancer

被引：0
|
作者：
Robert A. Gardiner
Freddie C. Hamdy
机构：
[1] University of Queensland Centre for Clinical Research,Nufffield Department of Surgery
[2] Royal Brisbane and Women’s Hospital,undefined
[3] John Radcliffe Hospital,undefined
来源：
World Journal of Urology | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：411 / 414
页数：3
相关论文
共 50 条
  • [31] Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer
    Aizer, Ayal A.
    Chen, Ming-Hui
    Hattangadi, Jona
    D'Amico, Anthony V.
    [J]. BJU INTERNATIONAL, 2014, 113 (01) : 43 - 50
  • [32] VARIATION IN GUIDELINE-CONCORDANT CONSERVATIVE MANAGEMENT FOR LOW-RISK PROSTATE CANCER
    Loeb, Stacy
    Walter, Dawn
    Byrne, Nataliya
    Makarov, Danil
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E632 - E632
  • [33] Contemporary management and pathologic outcomes of men with low- and very low-risk prostate cancer
    Ho, Austin Y.
    Li, Eric
    Bennett, Richard
    Aguiar, Jonathan
    Kumar, Sai
    Neill, Clayton
    Schaeffer, Edward M.
    Patel, Hiten Dilip
    Ross, Ashley
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 297 - 297
  • [34] What is the molecular pathology of low-risk prostate cancer?
    Hemamali Samaratunga
    Jonathan I. Epstein
    [J]. World Journal of Urology, 2008, 26 : 431 - 436
  • [35] Racial Disparities in Low-Risk Prostate Cancer Reply
    Mahal, Brandon A.
    Huang, Franklin W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (17): : 1727 - 1728
  • [36] mTOR inhibitors for treatment of low-risk prostate cancer
    Liss, Michael A.
    Rickborn, Lanette
    DiGiovanni, John
    Bacich, Dean
    DeGraffenried, Linda A.
    Parihar, Manish
    Thompson, Ian M.
    Sharp, Zelton Dave
    [J]. MEDICAL HYPOTHESES, 2018, 117 : 63 - 68
  • [37] Active surveillance preferred for low-risk prostate cancer
    Bagcchi, Sanjeet
    [J]. LANCET ONCOLOGY, 2015, 16 (08): : E384 - E384
  • [38] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
    Augustin, Herbert
    Mayerhofer, Katrin
    Seles, Maximilian
    Pummer, Karl
    [J]. UROLOGIA INTERNATIONALIS, 2015, 95 (02) : 125 - 131
  • [39] What is the molecular pathology of low-risk prostate cancer?
    Samaratunga, Hemamali
    Epstein, Jonathan I.
    [J]. WORLD JOURNAL OF UROLOGY, 2008, 26 (05) : 431 - 436
  • [40] Chemical Castration and Survival in Low-risk Prostate Cancer
    van der Poel, Henk G.
    [J]. EUROPEAN UROLOGY, 2009, 56 (04) : 617 - 618
12345